The Blood Biomarkers of Thyroid Cancer
Weiran Wang, Jingtao Chang, Baosong Jia, Jing Liu First Hospital of Shanxi Medical University, General Surgery Department, Taiyuan, Shanxi, People’s Republic of ChinaCorrespondence: Jing Liu Email liujing5585@163.comIntroduction: With the gradual increase in the incidence of thyroid cancer...
Main Authors: | Wang W, Chang J, Jia B, Liu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/the-blood-biomarkers-of-thyroid-cancer-peer-reviewed-article-CMAR |
Similar Items
-
Current Status and Future Perspectives in Differentiated Thyroid Cancer
by: Tae Yong Kim, et al.
Published: (2014-09-01) -
Autoimmune thyroiditis in blood disease
by: Yu E Vinogradova, et al.
Published: (2003-12-01) -
Diagnostic performance of the modified Korean Thyroid Imaging Reporting and Data System for thyroid malignancy according to nodule size: a comparison with five society guidelines
by: Dong Gyu Na, et al.
Published: (2021-10-01) -
The Potential of Metabolomics in the Diagnosis of Thyroid Cancer
by: Margarida Coelho, et al.
Published: (2020-07-01) -
Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
by: Wei Liu, et al.
Published: (2023-09-01)